Miriam Llorian-Sopena

13PUBLICATIONS
134CO-AUTHORS
Haematological tumoursMolecular targetsHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental law
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 04, 2025
Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny.

Hector Huerga Encabo, Giuseppe D'Agostino, Katherine Sturgess

|Sep 26, 2025
EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers.

Marija Maric, Sandra Segura-Bayona, Raviprasad Kuthethur

|Mar 11, 2025
Clonal hematopoiesis landscape in frequent blood donors.

Darja Karpova, Hector Huerga Encabo, Elisa Donato

|Feb 21, 2025
WNK1-dependent water influx is required for CD4+ T cell activation and T cell-dependent antibody responses.

Joshua Biggs O'May, Lesley Vanes, Leonard L de Boer

|Dec 03, 2024
Epi-microRNA mediated metabolic reprogramming counteracts hypoxia to preserve affinity maturation.

Rinako Nakagawa, Miriam Llorian, Sunita Varsani-Brown

|Aug 16, 2024
Loss of ARID3A perturbs intestinal epithelial proliferation-differentiation ratio and regeneration.

Nikolaos Angelis, Anna Baulies, Florian Hubl

Pageof 3